Interleukin-6 (IL-6) is a multifunctional cytokine which plays an important role in a wide
range of biologic activities in different types of cell including tumor cells. IL-6 is involved in …

Background Anti-cancer therapies lead to chronic non-resolving inflammation and reduced
immune function. One potential therapy is exercise training, but the effectiveness of these …

Disease progression in cancer is dependent on the complex interaction between the tumor
and the host inflammatory response. There is substantial evidence in advanced cancer that …

Purpose A systematic literature review was done to determine the relationship between
elevated CRP and prognosis in people with solid tumors. C-reactive protein (CRP) is a …

As a pleiotropic cytokine, interleukin-6 (IL-6) not only regulates the cellular immune
response, but it also promotes tumor development by activating multiple carcinogenic …

Objective: In tumor patients, IL-6 appears to be one component of a consistent cancer-
associated cytokine network resulting in both a systemic immune stimulation and a …

Progressive involuntary weight loss, in particular the loss of lean tissue, is common in
patients with advanced cancer and has long been recognised to result in a deterioration in …

Gastrointestinal cancer (GI) is a major health problem. Patients with gastric, pancreatic,
colorectal, bile duct and gall bladder cancer often have advanced disease at the time of …

The objective of this study was to review and summarise the published evidence for an
association between circulating concentrations of C reactive protein (CRP) and cancer …

Introduction It is now clear that inflammation and cancer initiation and progression are
linked. Interleukin-6 (IL-6) is a pleiotropic inflammatory cytokine with described cancer …